30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Medicus Pharma Ltd (MDCX)

Track

The most recent insider trading activity occurred on May 20, 2025, with significant sell transactions by VELOCITY FUND PARTNERS, LP. Prior to this, in November 2024, two Senior Officers made buy transactions. Earlier in June 2024, several Senior Officers and a Director also engaged in buy transactions.
Stock chart
Ticker: MDCX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
VELOCITY FUND PARTNERS, LP
2 sales — total 23,646,440 USD
Sale 20 May 2025
Value US$2,494,294.81 | Price 284.44 | Shares 60,166
Proposed sale 20 May 2025
Value US$936,529.21 | Price 418.86 | Shares 81,403
Buy 15 Nov 2024
Value US$1,367,394.05 | Price 261.95 | Shares 17,822
Buy 15 Nov 2024
Value US$99,998.25 | Price 4.13 | Shares 24,242
Buy 28 Jun 2024
Value US$1,527.12 | Price 1.23 | Shares 1,245
Buy 28 Jun 2024
Value US$2,291.29 | Price 1.23 | Shares 1,868
Buy 28 Jun 2024
Value US$2,490.00 | Price 2.00 | Shares 1,245
Buy 28 Jun 2024
Value US$381.47 | Price 1.23 | Shares 311
Buy 28 Jun 2024
Value US$4,582.58 | Price 1.23 | Shares 3,736
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-21 2025-05-20 S Sale
3.4
VELOCITY FUND PARTNERS, LP
Large shareholder
60,166 +1.9%
284.44
US$2,494,295 		60,166 +1.9% 284.44 US$2,494,295
2025-05-20 2025-05-20 PrS Proposed sale
3.4
VELOCITY FUND PARTNERS, LP

Major Shareholders
81,403
418.86
US$936,529 		81,403 418.86 US$936,529
2024-11-20 2024-11-15 B Purchase
Quinlan, James P

Senior Officer of Issuer

Officer
17,822 -0.5%
261.95
US$1,367,394 		17,822 -0.5% 261.95 US$1,367,394
2024-11-20 2024-11-15 B Purchase
Brennan, Jr., Edward Joseph

Senior Officer of Issuer

Officer
24,242 +38.8%
4.13
US$99,998 		24,242 +38.8% 4.13 US$99,998
2024-07-26 2024-06-28 B Purchase
Quinlan, James P

Senior Officer of Issuer

Officer
1,245 +0.6%
1.23
US$1,527 		1,245 +0.6% 1.23 US$1,527
2024-07-26 2024-06-28 B Purchase
Monaco, Erica Lee

Senior Officer of Issuer

Officer
1,868 +2.5%
1.23
US$2,291 		1,868 +2.5% 1.23 US$2,291
2024-07-26 2024-06-28 B Purchase
Lavelle, Francis W.

Director of Issuer

Non-Executive Director
1,245 +2.5%
2.00
US$2,490 		1,245 +2.5% 2.00 US$2,490
2024-07-26 2024-06-28 B Purchase
Bonner, Carolyn

Senior Officer of Issuer

Officer
311 +0.8%
1.23
US$381 		311 +0.8% 1.23 US$381
2024-07-26 2024-06-28 B Purchase
Bokhari, Raza

Director of Issuer, Senior Officer of Issuer

Executive Director
3,736 +0.2%
1.23
US$4,583 		3,736 +0.2% 1.23 US$4,583
Explore more

More insider trading research around Medicus Pharma Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America